risedronate sodium · Medicine question

How does risedronate sodium reduce bone resorption?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Risedronate sodium binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption, reducing bone turnover while preserving osteoblast activity and bone mineralisation.

Sources for this answer

Risedronate Sodium 35 mg Film-coated TabletsSandoz Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated 15 December 2020

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

Which fracture risks are risedronate sodium 5 mg film-coated tablets in the Aspire Pharma Ltd product indicated to reduce in postmenopausal osteoporosis?Can risedronate sodium be used while breastfeeding?Does the Sovereign Medical product risedronate sodium 35 mg film-coated tablets contain lactose monohydrate?How much lactose does each risedronate sodium 35 mg film-coated tablet in the Aspire Pharma Ltd product contain?How much lactose monohydrate does each risedronate sodium 35 mg film-coated tablet in the Sandoz Limited product contain?

loading page…

Answer

Sources for this answer

More questions about risedronate sodium

Answer

Sources for this answer

More questions about risedronate sodium

risedronate sodium

More clinical questions?